877 related articles for article (PubMed ID: 24852153)
21. Incidence and risk factors for retinopathy of prematurity in the West Black Sea region, Turkey.
Alpay A; Uğurbaş SH
Turk J Pediatr; 2012; 54(2):113-8. PubMed ID: 22734296
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity.
Ehmann D; Greve M
Can J Ophthalmol; 2014 Apr; 49(2):228-31. PubMed ID: 24767234
[TBL] [Abstract][Full Text] [Related]
24. [Retinopathy of prematurity--screening results].
Vătavu I; Nascutzy C; Ciomârtan T; Brezan F; Anca I; Stoicescu S
Oftalmologia; 2010; 54(1):110-7. PubMed ID: 20540379
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity.
Minturn R; Hartigan K; Vegunta S; Boente C; Golzarri-Arroyo L; Hynes E; Laughlin E; Haider K; Kua KL
BMC Ophthalmol; 2024 May; 24(1):220. PubMed ID: 38790043
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of retinopathy of prematurity after ranibizumab treatment.
Wong RK; Hubschman S; Tsui I
Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
[TBL] [Abstract][Full Text] [Related]
28. Retinopathy of prematurity in a tertiary care hospital in eastern Nepal.
Adhikari S; Badhu BP; Bhatta NK; Rajbhandari RS; Kalakheti BK
JNMA J Nepal Med Assoc; 2008; 47(169):24-7. PubMed ID: 18552888
[TBL] [Abstract][Full Text] [Related]
29. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Retinopathy of Prematurity in Bahrain, 2002-2011.
Al Alawi EK; Al Omran MS; Al Bahrana EH
Middle East Afr J Ophthalmol; 2015; 22(3):335-9. PubMed ID: 26180473
[TBL] [Abstract][Full Text] [Related]
31. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
[TBL] [Abstract][Full Text] [Related]
32. Incidence and severity of retinopathy of prematurity in Turkey.
Bas AY; Koc E; Dilmen U;
Br J Ophthalmol; 2015 Oct; 99(10):1311-4. PubMed ID: 25868788
[TBL] [Abstract][Full Text] [Related]
33. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
[TBL] [Abstract][Full Text] [Related]
34. Laser-ranibizumab treatment for retinopathy of prematurity in umbral-preumbral disease. Three years of experience.
Orozco-Gómez LP; Hernández-Salazar L; Moguel-Ancheita S; Ramírez-Moreno MA; Morales-Cruz MV
Cir Cir; 2011; 79(3):207-214, 225-32. PubMed ID: 22380989
[TBL] [Abstract][Full Text] [Related]
35. [New therapeutic approaches in the treatment of retinopathy of prematurity].
Jandeck C
Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
[TBL] [Abstract][Full Text] [Related]
36. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
37. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey.
Gunay M; Celik G; Tuten A; Karatekin G; Bardak H; Ovali F
PLoS One; 2016; 11(8):e0161692. PubMed ID: 27548628
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China.
Chen Y; Li XX; Yin H; Gilbert C; Liang JH; Jiang YR; Zhao MW;
Br J Ophthalmol; 2008 Mar; 92(3):326-30. PubMed ID: 18303154
[TBL] [Abstract][Full Text] [Related]
40. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors.
Sarikabadayi YU; Aydemir O; Ozen ZT; Aydemir C; Tok L; Oguz SS; Erdeve O; Uras N; Dilmen U
Ophthalmic Epidemiol; 2011 Dec; 18(6):269-74. PubMed ID: 22053836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
